
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
ASO Author Reflections: Is Mesothelin a Promising Option for Molecular Targeted Therapies in Triple Negative Breast Cancer?
Journal: Annals of surgical oncology
Published: March 21, 2025
Mesothelin (MSLN) is Highly Expressed in Triple Negative Breast Cancer and is Associated with Enhanced Cell Proliferation and Proinflammatory Tumor Microenvironment.
Journal: Annals of surgical oncology
Published: November 04, 2024
Chemotherapy switch for nonresponse or progression on neoadjuvant chemotherapy for pancreatic adenocarcinoma.
Journal: Journal of surgical oncology
Published: July 08, 2024
Extrahepatic biliary neuroendocrine tumors: A national cancer database analysis.
Journal: Heliyon
Published: May 08, 2024
Contemporary outcomes for resected type 1-3 gastroesophageal junction adenocarcinoma: a single-center experience.
Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
Published: January 09, 2024
Biology of Mesothelin and Clinical Implications: A Review of Existing Literature.
Journal: World journal of oncology
Published: July 05, 2023
High Mesothelin expression in pancreatic adenocarcinoma is associated with aggressive tumor features but not prognosis.
Journal: American journal of cancer research
Published: May 02, 2023
Age Determines Adjuvant Chemotherapy Use in Resected Stage II Colon Cancer.
Journal: Diseases of the colon and rectum
Published: December 13, 2021
Novel Humanized Mesothelin-Expressing Genetically Engineered Mouse Models Underscore Challenges in Delivery of Complex Therapeutics to Pancreatic Cancers.
Journal: Molecular cancer therapeutics
Published: February 08, 2021
Trends and Predictors of Failure of Minimally Invasive Surgery for Gastric GIST.
Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
Published: June 16, 2020
Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors.
Journal: Biomolecules
Published: May 31, 2020
Last Updated: 09/26/2026